selected scholarly activity
-
conferences
- Cancer and Pregnancy Outcomes: An Overview of Existing Knowledge and Preliminary Results of a Multicenter Study. Birth Defects Research Part A: Clinical and Molecular Teratology. 446-446. 2016
- Impact of health care professional interventions on completion of therapy in patients receiving high-dose interferon-alfa 2b adjuvant therapy for high-risk melanoma.. Journal of Clinical Oncology. e20038-e20038. 2014
- A Low Noise Op-amp Transimpedance Amplifier for LIDAR applications. 2014 21ST IEEE INTERNATIONAL CONFERENCE ON ELECTRONICS, CIRCUITS AND SYSTEMS (ICECS). 590-593. 2014
- A prospective study to evaluate the role of 2-[18f] fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography (PET), breast magnetic resonance imaging (MRI), and breast ultrasonography in monitoring tumor responses in patients with locally advanced breast cancer (LABC) undergoing neoadjuvant chemotherapy.. Journal of Clinical Oncology. 595-595. 2010
- AMG 479 in relapsed or refractory Ewing's family tumors (EFT) or desmoplastic small round cell tumors (DSRCT): Phase II results.. Journal of Clinical Oncology. 10001-10001. 2010
- Interleukin-21 (IL-21) activity in patients (pts) with metastatic melanoma (MM).. Journal of Clinical Oncology. 8507-8507. 2010
- Primary tumor and patient characteristics in breast cancer as predictors of adjuvant chemotherapy regimen: A regression model. Journal of Clinical Oncology. 2009
- Effects of nutritional intervention in non-small cell lung cancer patients with different levels of systemic inflammation. Journal of Clinical Oncology. 20631-20631. 2008
- Peripheral quantitative computed tomography (pQCT) reproducibility of volumetric bone density measurements at the radius and tibia in healthy women. Journal of Bone and Mineral Research. S194-S194. 2007
- The effect of doxycycline on bone turnover and tumor markers in breast cancer (BC) patients with skeletal metastases. Journal of Clinical Oncology. 3198-3198. 2005
- The effect of doxycycline on bone turnover and tumor markers in breast cancer (BC) patients with skeletal metastases.. Journal of Clinical Oncology. 240S-240S. 2005
- Effect of letrozole versus placebo on bone mineral density in women completing >= 5 years (yrs) of adjuvant tamoxifen: ncic ctg ma.17b. Breast Cancer Research and Treatment. S36-S36. 2004
- Phase II study of perifosine in metastatic or advanced breast cancer.. Breast Cancer Research and Treatment. S67-S68. 2004
- Results of a randomized phase II study of two schedules of bryostatin-I in patients with malignant melanoma: experience with the multivariate stopping rule. European Journal of Cancer. S374-S374. 1999
-
journal articles
- Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole. Journal of Clinical Oncology. 42:2887-2898. 2024
- Abstract PO1-27-10: Adjunctive statistical standardization of quantitated machine image analysis of Estrogen and Progesterone Receptors: CCTG MA.27 trial. Cancer Research. 84. 2024
- Neurocognitive outcomes following fetal exposure to chemotherapy for gestational breast cancer: A Canadian multi-center cohort study. Breast. 58:34-41. 2021
- The Role of Denosumab for Surgical Outcomes in Patients with Giant Cell Tumour of Bone: A Systematic Review. Current Oncology. 28:1302-1313. 2021
- Feasibility and Effectiveness of Implementing a Novel Exercise and Self-Management Programme during Chemotherapy for Women with Breast Cancer: A Pilot Randomized Controlled Trial. Physiotherapy Canada. Physiotherapie Canada. 72:271-281. 2020
- Bridging the gap: incorporating exercise evidence into clinical practice in breast cancer care. Supportive Care in Cancer. 28:897-905. 2020
- Interventions for reducing unplanned paediatric admissions: an observational study in one hospital. BMJ Paediatrics Open. 2:e000235-e000235. 2018
- Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. Breast Cancer Research. 18:110. 2016
- Physical Activity and Breast Cancer: A Qualitative Study on the Barriers to and Facilitators of Exercise Promotion from the Perspective of Health Care Professionals. Physiotherapy Canada. Physiotherapie Canada. 68:383-390. 2016
- A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas—NCIC-CTG IND 200. Annals of Oncology. 26:973-981. 2015
- Safe Handling of Cytotoxics: Guideline Recommendations. Current Oncology. 22:27-37. 2015
- Oncologists’ Protocol and Coping Strategies in Dealing with Patient Loss. Death Studies. 37:937-952. 2013
- Oncologists' Strategies and Barriers to Effective Communication About the End of Life. JCO Oncology Practice. 9:e129-e135. 2013
- Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial. Journal of Clinical Oncology. 31:1398-1404. 2013
- Difficult Patient Loss and Physician Culture for Oncologists Grieving Patient Loss. Journal of Palliative Medicine. 15:1254-1260. 2012
- What do oncologists want?. Supportive Care in Cancer. 20:2627-2632. 2012
- Interleukin-21 Has Activity in Patients With Metastatic Melanoma: A Phase II Study. Journal of Clinical Oncology. 30:3396-3401. 2012
- Nature and Impact of Grief Over Patient Loss on Oncologists' Personal and Professional Lives. JAMA Internal Medicine. 172:964-966. 2012
- Phase II Study of Ganitumab, a Fully Human Anti–Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors. Journal of Clinical Oncology. 30:1849-1856. 2012
- Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model. Cancer Chemotherapy and Pharmacology. 68:661-668. 2011
- Reproducibility of Peripheral Quantitative Computed Tomography Measurements at the Radius and Tibia in Healthy Pre- and Postmenopausal Women. Canadian Association of Radiologists Journal. 62:183-189. 2011
- Cortical and trabecular bone at the radius and tibia in postmenopausal breast cancer patients: A Peripheral Quantitative Computed Tomography (pQCT) study. Bone. 48:218-224. 2011
- An assessment of the level of osteoporosis knowledge in postmenopausal breast cancer patients. International Journal of Orthopaedic and Trauma Nursing. 14:150-158. 2010
- Primary tumor and patient characteristics in breast cancer as predictors of adjuvant chemotherapy regimen: A regression model. Journal of Clinical Oncology. 27:e11632-e11632. 2009
- A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 113:573-581. 2008
- A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma. Cancer. 113:573-581. 2008
- A phase II study of ispinesib (SB-715992) in patients with metastatic or recurrent malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group trial. Investigational New Drugs. 26:249-255. 2008
- A Phase 2 study of perifosine in advanced or metastatic breast cancer. Breast Cancer Research and Treatment. 108:87-92. 2008
- Cysteine-Rich Protein Reverses Weight Loss in Lung Cancer Patients Receiving Chemotherapy or Radiotherapy. Antioxidants and Redox Signaling. 10:395-402. 2008
- Effectiveness of sperm banking in adolescents and young adults with cancer. Cancer. 110:1125-1129. 2007
- A randomized trial of computer and pamphlet-based versions of the Decision Board (DB). Journal of Clinical Oncology. 25:6508-6508. 2007
- A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial. Investigational New Drugs. 24:435-439. 2006
- Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17. Journal of Clinical Oncology. 24:3629-3635. 2006
- Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma. Investigational New Drugs. 22:315-322. 2004
- The Initial Health Assessment: an intervention to identify the supportive care needs of cancer patients. Supportive Care in Cancer. 12:19-24. 2004
- Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer. Journal of the National Cancer Institute. 95:581-587. 2003
- A Randomized Phase II Study of Two Schedules of Bryostatin-1 (NSC339555) in Patients with Advanced Malignant Melanoma – A National Cancer Institute of Canada Clinical Trials Group Study. Investigational New Drugs. 20:407-412. 2002
- ETS Proteins and MMPs: Partners in Invasion and Metastasis. Current Drug Targets. 3:359-367. 2002
- Expression of Ets-related Transcription Factors and Matrix Metalloproteinase Genes in Human Breast Cancer Cells. Breast Cancer Research and Treatment. 72:227-232. 2002
- Doxycycline decreases tumor burden in a bone metastasis model of human breast cancer.. Cancer Research. 62:1588-1591. 2002
- Genetically modified dendritic cells in cancer therapy: Implications for transfusion medicine. Transfusion Medicine Reviews. 15:292-304. 2001
- Guest Editor. Oncogene. 19:6549-6549. 2000
- Male Sexual Dysfunction in Mice Bearing Targeted Mutant Alleles of thePEA3 etsGene. Molecular and Cellular Biology. 20:9337-9345. 2000
- Correction: Corrigendum. Oncogene. 19:5039-5039. 2000
- The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.. Oncogene. 19:5039. 2000
- Immunolocalization of matrix metalloproteinases and their inhibitors in clinical specimens of bone metastasis from breast carcinoma. Clinical and Experimental Metastasis. 18:463-470. 2000
- Humanised antibodies for cancer therapy. Part 2: Review of clinical trials with rituximab and trastuzumab. Current Oncology. 6:131-137. 1999
- Bisphosphonates for bone metastases in breast cancer patients: Trial design issues and evaluation of published studies. Current Oncology. 5:181-187. 1998
- Retinoids and Lung Cancer. Advances in Organ Biology. 3:261-287. 1997
- The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.. Oncogene. 13:1323-1333. 1996
- The arotinoids: early clinical experience and discussion of future development.. Leukemia. 8:1817-1824. 1994
- The arotinoids: early clinical experience and discussion of future development.. Leukemia. 8 Suppl 3:S42-S49. 1994
- Activation of Escherichia coli F1-ATPase by lauryldimethylamine oxide and ethylene glycol: relationship of ATPase activity to the interaction of the .epsilon. and .beta. subunits. Biochemistry. 29:4335-4340. 1990
- Antiepileptic drugs, hepatic enzyme induction and raised serum alkaline phosphatase isoenzymes.. International Journal of Clinical Pharmacology Research. 10:319-323. 1990
- SCREENING FOR INHERITED METABOLIC DISEASES IN ADULTS WITH NEUROLOGICAL DISEASE. The Lancet. 1:1101-1101. 1988
- The epsilon subunit and inhibitory monoclonal antibodies interact with the carboxyl-terminal region of the beta subunit of Escherichia coli F1-ATPase.. Journal of Biological Chemistry. 262:10706-10711. 1987
- .epsilon. Subunit of Escherichia coli F1-ATPase: effects on affinity for aurovertin and inhibition of product release in unisite ATP hydrolysis. Biochemistry. 26:4488-4493. 1987
- Activation and inhibition of the Escherichia coli F1-ATPase by monoclonal antibodies which recognize the ϵ subunit. Molecular Cell Biology Research Communications. 253:73-80. 1987
- Column centrifugation generates an intersubunit disulfide bridge in Escherichia coli F1-ATPase. The FEBS Journal. 161:513-518. 1986
- Monoclonal antibodies to Escherichia coli F1-ATPase. Correlation of binding site location with interspecies cross-reactivity and effects on enzyme activity.. Journal of Biological Chemistry. 260:10418-10425. 1985
- Physical activity and breast cancer: Results of a focus group to devise novel exercise interventions for women with breast cancer. Clinical Nursing Studies. 6:39-39.